Effector Therapeutics Inc (EFTR)

NASDAQ
6.420
-0.230(-3.46%)
  • Volume:
    29,550
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    6.300 - 6.888

EFTR Overview

Prev. Close
6.65
Day's Range
6.3-6.888
Revenue
1.12M
Open
6.65
52 wk Range
5.54-40.42
EPS
-
Volume
29,550
Market Cap
259.19M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
119,957
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
40,371,726
Next Earnings Date
Mar 02, 2022
What is your sentiment on Effector Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Effector Therapeutics Inc Company Profile

Employees
54

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral
  • Whats the expecting price
    0
    • Why is this up so much? Merger news?
      0
      • They already f cked people who bought above 40 50 lol I would stay away from this
        1
        • Trying to buy since 20
          0
          • Dont buy anymore
            0
        • Why i cant buy this stock
          0
          • Amazing
            0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.